Ally Bridge Group (Ny) LLC Iovance Biotherapeutics, Inc. Transaction History

Ally Bridge Group (Ny) LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $5.04 Million - $7.77 Million	-406,986 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $1.35 Million - $2.47 Million	46,986 Added 13.05%	406,986 $12.9 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $10.1 Million - $18.1 Million	360,000 New	360,000 $16.7 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.